Clinical and immunologic responses in melanoma patients vaccinated with MAGE-A3-genetically modified lymphocytes.
Int J Cancer
; 132(11): 2557-66, 2013 Jun 01.
Article
in En
| MEDLINE
| ID: mdl-23151995
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
T-Lymphocytes
/
Genetic Therapy
/
Cancer Vaccines
/
Melanoma
/
Antigens, Neoplasm
/
Neoplasm Proteins
Type of study:
Observational_studies
/
Prognostic_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Int J Cancer
Year:
2013
Document type:
Article
Affiliation country:
Italia
Country of publication:
Estados Unidos